Is CMRAW or DIVO a better dividend investment in 2026?

CMRAW currently yields 10362.69% with a 5% 5-year dividend growth rate. DIVO yields 6.62% with 5% growth. The better choice depends on your goal: CMRAW offers higher current income.

What is the dividend yield difference between CMRAW and DIVO?

CMRAW has a forward dividend yield of 10362.69% ($2.00/share annually). DIVO yields 6.62% ($2.91/share annually). The yield gap is 10356.07 percentage points.

Home › Compare › CMRAW vs DIVO

CMRAW vs DIVO: Dividend Comparison 2026

CMRAW yields 10362.69% · DIVO yields 6.62%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CMRAW wins by $78335784849600944.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CMRAW

● Live price

10362.69%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$78335784849600944.00M

Annual income

$76,876,438,600,915,240,000,000.00

Full CMRAW calculator →

DIVO

● Live price

6.62%

Share price

$44.00

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$31.0K

Annual income

$1,008.47

Full DIVO calculator →

Portfolio growth — CMRAW vs DIVO

📍 CMRAW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CMRAW	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CMRAW + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CMRAW pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMRAW

Annual income on $10K today (after 15% tax)

$880,829.02/yr

After 10yr DRIP, annual income (after tax)

$65,344,972,810,777,950,000,000.00/yr

DIVO

Annual income on $10K today (after 15% tax)

$562.67/yr

After 10yr DRIP, annual income (after tax)

$857.20/yr

At 15% tax rate, CMRAW beats the other by $65,344,972,810,777,950,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMRAW + DIVO for your $10,000?

CMRAW: 50%DIVO: 50%

100% DIVO50/50100% CMRAW

Portfolio after 10yr

$39167892424800472.00M

Annual income

$38,438,219,300,457,620,000,000.00/yr

Blended yield

98.14%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMRAW buys

DIVO buys

No recent congressional trades found for CMRAW or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCMRAWDIVO

Forward yield	10362.69% ✓	6.62%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$78335784849600944.00M ✓	$31.0K
Annual income after 10y	$76,876,438,600,915,240,000,000.00 ✓	$1,008.47
Total dividends collected	$78238734181699024.00M ✓	$8.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CMRAW vs DIVO ($10,000, DRIP)

Year	CMRAW Portfolio	CMRAW Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$1,046,969	$1,036,269.43	$11,362	$661.96	+$1.04M → CMRAW
2	$102,516,745	$101,396,487.34	$12,860	$702.91	+$102.50M → CMRAW
3	$9,388,666,498	$9,278,973,581.18	$14,504	$743.56	+$9388.65M → CMRAW
4	$804,237,430,573	$794,191,557,419.90	$16,303	$783.73	+$804237.41M → CMRAW
5	$64,440,729,401,315	$63,580,195,350,601.93	$18,268	$823.31	+$64440729.38M → CMRAW
6	$4,830,127,690,198,710	$4,761,176,109,739,303.00	$20,408	$862.17	+$4830127690.18M → CMRAW
7	$338,693,420,711,903,550	$333,525,184,083,391,000.00	$22,737	$900.20	+$338693420711.88M → CMRAW
8	$22,219,525,310,042,270,000	$21,857,123,349,880,533,000.00	$25,266	$937.31	+$22219525310042.25M → CMRAW
9	$1,363,874,998,771,683,700,000	$1,340,100,106,689,938,500,000.00	$28,008	$973.42	+$1363874998771683.75M → CMRAW
10	$78,335,784,849,600,940,000,000	$76,876,438,600,915,240,000,000.00	$30,977	$1,008.47	+$78335784849600944.00M → CMRAW

CMRAW vs DIVO: Complete Analysis 2026

CMRAW — Stock

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

Full CMRAW Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this CMRAW vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMRAW vs SCHD CMRAW vs JEPI CMRAW vs O CMRAW vs KO CMRAW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.